Retinoid

18 marketed 21 in Phase 3 3 in Phase 2

This page covers all Retinoid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Retinoic acid receptor RXR-gamma, Retinoid acid receptors (RAR and RXR), Retinoic acid receptors (RAR-alpha, RAR-beta, RAR-gamma).

Targets

Retinoic acid receptor RXR-gamma · Retinoid acid receptors (RAR and RXR) · Retinoic acid receptors (RAR-alpha, RAR-beta, RAR-gamma) · Retinoic acid receptors (RAR-α, RAR-β, RAR-γ) · Retinoid X receptor (RXR), Retinoid acid receptor (RAR) · Retinoid X Receptor (RXR), Retinoid Acid Receptor (RAR) · Retinoid acid receptors (RAR), Retinoid X receptors (RXR) · Retinoic acid receptor gamma (RAR-γ) · Retinoic acid receptor gamma (RARγ) · Retinoid nuclear receptors (RAR and RXR)

Marketed (18)

Phase 3 pipeline (21)

Phase 2 pipeline (3)